Telo Genomics

telodx.com

Telo Genomics Corp. is a Canada-based molecular diagnostics company that provides vital molecular information to guide the management of life-threatening cancers. The company has developed a telomere-based platform, Telo View®, which measures the 3D structure and spatial organization of telomeres to predict genomic instability and inform treatment decisions. With applications in multiple cancers and Alzheimer's disease, Telo Genomics has been validated through over 160 peer-reviewed publications and 30+ clinical studies involving more than 3,000 patients, positioning itself as a leader in the molecular diagnostics market.